Patient factors affecting 18F FDG uptake in children

Pradipta Debnath1, Andrew T Trout2

  • 1Department of Radiology, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Kasota Building MLC 5031, Cincinnati, OH 45229, United States of America.

Clinical Imaging
|January 31, 2024
PubMed

Insights

Physiologic uptake of Fluorodeoxyglucose (FDG) in children undergoing PET/CT is associated with age and weight. Increasing injected dose per kilogram may not improve liver signal-to-noise ratio in young children.

Area of Science:

  • Nuclear Medicine
  • Pediatric Imaging
  • Radiopharmaceuticals

Background:

  • 18F FDG PET/CT is a crucial diagnostic tool in pediatric oncology.
  • Optimizing image quality in children is essential for accurate diagnosis and treatment monitoring.
  • Understanding physiologic FDG uptake patterns in pediatric patients is key to image quality improvement.

Purpose of the Study:

  • To characterize the physiologic uptake of 18F FDG in children undergoing PET/CT.
  • To identify factors influencing FDG uptake and image quality in pediatric patients.
  • To inform strategies for optimizing FDG PET/CT image quality in pediatric populations.

Main Methods:

  • Retrospective analysis of 193 18F FDG PET/CT scans from 139 pediatric patients.
  • Measurement of liver and thigh muscle counts and SUVmean-bw using 3D spherical ROIs.
  • Assessment of associations between counts, SUVs, liver SNR, and patient predictors (age, weight, injected activity) via correlation and regression analyses.

Main Results:

  • Liver uptake (counts and SUVmean-bw) strongly correlated with patient weight, age, and total injected activity.
  • Thigh muscle uptake was associated with injected activity per kilogram.
  • Multivariable analysis identified body weight and age as significant independent predictors of liver uptake.
  • Liver SNR showed moderate association with predictors, but not significantly with injected activity per kilogram.

Conclusions:

  • Liver 18F FDG uptake in children is significantly associated with age and body weight.
  • Increasing injected 18F FDG dose per kilogram may not enhance liver image quality (SNR) in young children.
  • These findings provide insights for optimizing pediatric FDG PET/CT protocols.
Abstract

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
122
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
92
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K